Statins impair antitumor effects of rituximab by inducing conformational changes of CD20 - Wikidata - wikimedia - TriplyDB

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

http://www.wikidata.org/entity/Q28472420

about

Molecular Mechanism for Cellular Response to β-Escin and Its Therapeutic Implications The potential effect of statins on rituximab immunotherapy.Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era A preliminary study on the interaction between Asn-Gly-Arg (NGR)-modified multifunctional nanoparticles and vascular epithelial cells B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses.Statins impair glucose uptake in human cells.Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells.Selective role of mevalonate pathway in regulating perforin but not FasL and TNFalpha release in human Natural Killer cells Rituximab resistance.A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF).Statins impair glucose uptake in tumor cells Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer Targeting inflammatory pathways in chronic lymphocytic leukemia.Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention.Statins do not influence long-term rituximab clinical efficiency in rheumatoid arthritis patients.Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia.Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.Investigational immunotherapeutics for B-cell malignancies.Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.Rituximab biosimilars.Learning from berberine: Treating chronic diseases through multiple targets.HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence?Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.Associations between statin use and non-Hodgkin lymphoma (NHL) risk and survival: a meta-analysis.Development of Novel Anti-Cd20 Monoclonal Antibodies and Modulation in Cd20 Levels on Cell Surface: Looking to Improve Immunotherapy Response The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent.Prenyltransferases regulate CD20 protein levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity Characterization of N-cadherin unbinding properties in non-malignant (HCV29) and malignant (T24) bladder cells.Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression.Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis.Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.Effect of concomitant statin use on rituximab treatment for pemphigus and pemphigoid disorders: a case-based review.Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis.

P2860

Q28554614-D020DA74-5C86-4B4D-A899-C34A334DCAE5 Q33325581-43AC1D72-4178-450C-A57C-208C3F367285 Q33627714-39BB0EC0-6507-42A4-A770-E135ACAA57A1 Q33682897-87883B87-2B51-4F42-9228-34D1FDE37004 Q33721433-EA212850-56D8-48E7-826D-6AD947C77EDB Q33971785-7835C3C6-76B1-416B-AB7D-F49D29B1FCAF Q34419117-A16616B9-DA82-4ADC-843F-8354B9107644 Q34507114-FC9D9B53-8300-403F-9A80-AAD32B4DCF7A Q34717893-0ED15371-E282-48A5-B817-07CE25F4D949 Q35041270-18205D38-B5FF-4617-BF02-EC885663AF31 Q35679492-6BCBB3E3-09EB-4BFA-8EA3-7D4AB5643A09 Q35949773-460C9A2B-F24D-4658-97D9-BF0C1DB7C25D Q36213094-863783B8-F62B-4340-8E5D-72D89BEBE558 Q37124770-410F2704-E666-4469-8BCF-05DFB21793D1 Q37351312-040CD91A-7F48-4350-8BA0-1693D11C3841 Q37448352-0720A80C-064F-4829-BBCE-99FF725170DC Q37551567-3C33372E-C003-476E-BEC7-FD5390FD0867 Q37552790-E88678E1-2F95-4522-B460-F7CF66B940AC Q37613872-541759BE-4B8A-4D1C-A1DE-670A4E81C07F Q37667386-23CF9234-3C73-4270-BB29-D8820ABCDBA8 Q38026796-5A6CD0FF-2AB7-457E-9B74-C4D05334E4E4 Q38094203-D07646B7-51E9-4BDE-9C48-867AFF290016 Q38100232-605098AC-BB46-47EF-B129-1FD0D0ABF7ED Q38156718-12A42C5D-68ED-4CB9-AEC0-117CF67DCE98 Q38270419-EE6C7645-36AF-4F24-A601-C3849F15E661 Q38510965-18C218DF-B6E1-47AF-9ECE-7F03459BBEFD Q38611423-4B6FD72B-F240-48D0-A0AD-5BBC66C021DB Q38896113-DB729D37-C7DE-4246-9A2B-3324611F41F8 Q38906510-AC9170F4-B261-43F2-82EB-158EBC84835D Q38944928-A77FF0BD-D13F-4671-ABA8-61B645760D59 Q39306456-76D91098-609A-4730-A591-3ACB93F7EFFC Q39496000-D31DC5B9-D6FB-4808-8A78-54FA474CA882 Q40073860-DB098D25-3502-4AE0-AE0F-C5AE7C8FFA95 Q40197900-F33EE31F-FE99-4337-B5DE-AACD2047A33F Q42856089-FB1AFFDE-05EE-4183-AE96-9151A184E2D4 Q42913258-0D3CD97B-DA0F-4082-BF27-CEA298A0402C Q47802987-FCE53887-C161-47EC-A7BE-03286044AAD4 Q47929546-582D9414-2D94-49F1-B3A0-2C66133052D0 Q50099990-A5D590E0-7A01-42D0-A9BD-8F9BF9C822F7 Q50640571-64756E23-A8E9-441E-84B4-7187735CE8D1

P2860

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

http://www.wikidata.org/entity/Q28472420

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@ast

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@en

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@nl

type

label

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@ast

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@en

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@nl

prefLabel

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@ast

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@en

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@nl

P1433

Q28472420-E0BC691A-22F4-4717-BF05-B8E1A86CC5DA

P1476

Q28472420-59A1035D-A5D8-4542-A35C-032E8E10CBF5

P2093

Q28472420-0E39E633-8465-4747-A795-4A22865D2370

Q28472420-454A4E7B-1DAD-4C14-BC00-8C9D2B8CFE58

Q28472420-48B07D8D-2FA0-4436-AA3F-EFFF8C8AF3F5

Q28472420-62B48E53-6228-4EC1-B7F5-F117EA370046

Q28472420-74B96791-EFB6-445A-998A-8AD7FD71599D

Q28472420-7599F4CE-FC63-44C0-B050-F5EEF543AD3D

Q28472420-80DD8B5F-785E-486E-9D8B-1D6282CD4641

Q28472420-942AD29F-4E95-49CD-9B7D-16F548C9B504

Q28472420-A0CE2D15-0135-4F25-A356-8A9B1641748F

Q28472420-D757AC0E-FD12-49DA-94A7-60DA60463512

P2860

Q28472420-01D0F2CA-8D01-496A-98BC-92C9117B090C

Q28472420-032C495C-2B79-4EB6-8A8A-36BDEE22E50D

Q28472420-07D3AE76-5280-4C35-B326-3309CC23841E

Q28472420-0B74B996-96AD-423C-AB17-A4423B76E9FC

Q28472420-11DDCDB3-ECAC-4B1F-BA24-4EDA696A47FE

Q28472420-15C3A770-3D0E-4AC0-83EF-324828FFFDAD

Q28472420-196C3D19-6D04-4212-BBA1-95C9BE9BCB76

Q28472420-2AFF94D7-1258-40EC-93A6-44DDFB57EA78

Q28472420-2E574B92-E3BA-48F5-9295-12964E12099C

Q28472420-38777941-5EFE-4B94-85DA-F37832DCEA4F

P304

Q28472420-155AB779-CF79-4A68-B94C-AE68B0E601A7

P31

Q28472420-36058D26-0ABE-4F5F-BF02-88DAAC1596D6

P3181

Q28472420-173423F7-2FDE-4BC2-B7F0-C68543F072F5

P356

Q28472420-D9CA2F38-94CE-429A-B2A7-56B3D8697765

P407

Q28472420-D44C14B6-91DF-4D09-A554-926B5C5BF28B

P433

Q28472420-EC1F1E19-C770-4827-8F9B-D78F28AF12BA

P478

Q28472420-FCF431D7-4170-4E69-8320-3B7D9AC03EF5

P50

Q28472420-075900E3-15F0-4922-BD4D-8CC66E0A0839

Q28472420-13C9490D-158D-4183-A2D1-4FA2F1F6512F

Q28472420-2C6EFAD4-3CC9-47E3-B03F-1E02C02300BA

Q28472420-38D06018-F8D3-4E3A-B389-A6D6D525A671

Q28472420-4C3C7EDB-7186-47BC-9FE5-1E7F0CAA8CDB

Q28472420-50319791-9D86-4029-B25F-4144C32FFBF8

Q28472420-7EA9DBA4-933F-4264-BA9F-CD3941DCAFF9

Q28472420-9786D00F-6A1E-4368-BD57-6FE2A6A4D1F0

Q28472420-9E0C9469-F685-4115-B148-900BD826DF39

Q28472420-A2B77B57-D14B-4B86-A67F-E78FD37D3D31

P577

Q28472420-61F47BBA-1A9E-43A3-8A28-3E6CD3C0DAA0

P5875

Q28472420-902BF5CE-B060-4323-A3F4-D6C9B348445B

P698

Q28472420-6504B4D0-9ADF-45ED-915F-084DE130279D

P932

Q28472420-DB5FEE74-5536-4B0D-99DD-A2418282EED5

P3181

P356

JOURNAL.PMED.0050064

P1433

P1476

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20

@en

P2093

Elzbieta Gorska

http://www.w3.org/2001/XMLSchema#string

Ewa Wilczek

http://www.w3.org/2001/XMLSchema#string

Grzegorz W Basak

http://www.w3.org/2001/XMLSchema#string

Lukasz Bojarski

http://www.w3.org/2001/XMLSchema#string

Magdalena Winiarska

http://www.w3.org/2001/XMLSchema#string

Marcin Makowski

http://www.w3.org/2001/XMLSchema#string

Marek Jakobisiak

http://www.w3.org/2001/XMLSchema#string

Maria Wasik

http://www.w3.org/2001/XMLSchema#string

Patrick J Engelberts

http://www.w3.org/2001/XMLSchema#string

Piotr Mrowka

http://www.w3.org/2001/XMLSchema#string

P2860

Pleiotropic effects of statins

A cholesterol-dependent CD20 epitope detected by the FMC7 antibody

The biology of CD20 and its potential as a target for mAb therapy

A microcantilever device to assess the effect of force on the lifetime of selectin-carbohydrate bonds.

The epitope recognized by rituximab.

Intramembrane aspartic acid in SCAP protein governs cholesterol-induced conformational change.

Regulation of receptor function by cholesterol.

The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Who should receive HMG CoA reductase inhibitors?

P304

e64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3042729

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0050064

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Eliza Głodkowska-Mrówka

Paul Whi Parren

Tomasz Stokłosa

Małgorzata Lekka

Krzysztof Warzocha

Grzegorz M Wilczynski

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5486695

http://www.w3.org/2001/XMLSchema#string

P698

18366248

http://www.w3.org/2001/XMLSchema#string

P932

2270297

http://www.w3.org/2001/XMLSchema#string